ESMO Announces 2026 Society Award Recipients: Rebecca Fitzgerald, Dan A. Landau, Pilar Garrido and Antoni Ribas
The European Society for Medical Oncology (ESMO) has announced its 2026 award recipients, honoring leaders in cancer research, translational science, and clinical care. The awards recognize contributions ranging from early detection to immunotherapy.
Why it matters
Recognizing advancements in oncology is vital for fostering innovation in cancer treatment and improving global patient outcomes.
The European Society for Medical Oncology (ESMO) has announced the recipients of the 2026 ESMO Society Awards, recognising four oncology leaders for their contributions to cancer research, clinical care, translational science and leadership in the global oncology community.
The 2026 awards have been presented to Rebecca Fitzgerald , Dan A. Landau , Pilar Garrido and Antoni Ribas , whose work spans cancer prevention and early detection, cancer evolution, lung cancer, gender equity and cancer immunotherapy.
Rebecca Fitzgerald, Director of the Early Cancer Institute at the University of Cambridge, UK, has received the ESMO Award 2026 for her pioneering work in cancer prevention and early detection.
Her research has contributed to improving the identification of people at risk of oesophageal cancer and developing approaches to detect the disease at earlier, more treatable stages.
Fitzgerald’s work has also contributed to cancer screening and prevention strategies in the UK and across Europe.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in